(Q22248108)

English

Guillain–Barré Syndrome

scientific article

Guillain-Barré syndrome

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Guillain–Barré Syndrome (English)

0 references

main subject

Guillain–Barré syndrome

0 references

2

Hans-Peter Hartung

Hans-Peter

Hartung

1 reference

7 February 2023

1

Nobuhiro Yuki

Nobuhiro

Yuki

1 reference

7 February 2023

language of work or name

English

0 references

publication date

14 June 2012

0 references

published in

The New England Journal of Medicine

0 references

volume

366

0 references

page(s)

2294-2304

0 references

issue

24

0 references

cites work

Increased risk of Guillain-Barré Syndrome following recent herpes zoster: a population-based study across Taiwan

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Controlled trial prednisolone in acute polyneuropathy

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Guillain-Barré syndrome after exposure to influenza virus

2 references

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S1473-3099(10)70140-7

Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Guillain-Barré syndrome with ophthalmoplegia: clinicopathologic study of the central and peripheral nervous systems, including the oculomotor nerves.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Immunotherapy for Guillain-Barre syndrome: a systematic review

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

A clinical prognostic scoring system for Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Recurrent Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes

2 references

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1212/01.WNL.0000081231.08914.A1

Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Biomarkers in experimental models of antibody-mediated neuropathies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Guillain-Barré syndrome subtypes related to Campylobacter infection

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Anti-GT1a IgG in Guillain-Barré syndrome.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Anti-ganglioside antibody-mediated activation of RhoA induces inhibition of neurite outgrowth

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

A prospective study of physiotherapist prescribed community based exercise in inflammatory peripheral neuropathy

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Intravenous immunoglobulin therapy for Miller Fisher syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Respiratory muscle weakness in peripheral neuropathies.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Acute motor conduction block neuropathy Another Guillain-Barre syndrome variant

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Antiganglioside antibodies are associated with axonal Guillain–Barré syndrome: A Japanese–Italian collaborative study

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

A Guillain-Barré syndrome variant with prominent facial diplegia

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Pitfalls in electrodiagnosis of Guillain-Barre syndrome subtypes

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Supportive care for patients with Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Clinical features and prognosis of Miller Fisher syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Assessment of current diagnostic criteria for Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Unusual clinical variants and signs in Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Pain in Guillain-Barre syndrome: a long-term follow-up study

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Determination of pain and response to methylprednisolone in Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Early recognition of poor prognosis in Guillain-Barre syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

The Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

AHaemophilus influenzaeStrain Associated with Fisher Syndrome Expresses a Novel Disialylated Ganglioside Mimic†

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Selective Digestive Tract Decontamination Decreases Time on Ventilator in Guillain–Barré Syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Involvement of sensory fibres in axonal subtypes of Guillain-Barre syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Patterns of Guillain-Barre syndrome in children: results from a Mexican population

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1056/NEJMRA1114525

Identifiers

DOI

10.1056/NEJMRA1114525

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1421106

OpenCitations bibliographic resource ID

1421106

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1421106

(Q22248108)

Guillain–Barré Syndrome

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)